A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod

Clinical trial NCT04639115 · COMPLETED

Trial details

NCT number: NCT04639115
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Diseases Digestive System Diseases

Start date: 2020-12-18
Primary completion: 2022-04-06
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.